How should the evidence on IV drips be read?
IV drip therapy is not one thing. It covers hospital fluid resuscitation, prescribed iron and vitamin B12 replacement, and commercially marketed 'wellness' infusions. These sit at very different points on the evidence scale, and a claim proven for one does not transfer to the others.
Much of the confusion around intravenous drips comes from treating a single label as a single treatment. An infusion given in hospital to correct dehydration in a patient who cannot drink is a well-studied intervention with clear indications and monitoring requirements. A vitamin mixture sold to a healthy adult who wants more energy is a different proposition, tested against a much thinner body of published research.
This page separates those categories. It reports what trials and systematic reviews have actually found, including the places where the honest answer is that good evidence does not yet exist. Where a benefit is stated, the corresponding risks are stated alongside it.
General information only
Nothing on this page is a diagnosis, a prescription or a recommendation for any individual. Decisions about intravenous treatment should be made with a licensed doctor who has assessed the person in front of them.
What is IV therapy genuinely established for?
Intravenous therapy has a solid evidence base where a clinical problem cannot be corrected by mouth: fluid and electrolyte replacement in patients unable to drink or absorb adequately, intravenous iron in iron deficiency, and vitamin B12 replacement in pernicious anaemia or malabsorption. These are prescribed indications, confirmed by assessment and usually by blood tests.
Clinical rehydration and fluid replacement
Where a patient cannot take enough fluid orally — vomiting, severe diarrhoea, surgery, or an acute illness — intravenous fluids are standard care. UK NICE guidance sets out how volume, composition and rate should be prescribed and monitored, which is also why the same guidance treats inappropriate IV fluid as a source of harm.
Intravenous iron in iron deficiency
Intravenous iron is an established option when oral iron is not tolerated, not absorbed, or not working quickly enough. A Cochrane review of intravenous iron in adults with non-anaemic iron deficiency found it raised ferritin and haemoglobin and reduced fatigue compared with placebo, with fatigue rated moderate-quality evidence. The same review found a higher risk of mild adverse events in the intravenous iron group, and its authors remained uncertain about efficacy in this population because most outcomes rested on low-quality evidence.
Vitamin B12 where absorption is impaired
In pernicious anaemia the problem is absorption, not intake, so injected hydroxocobalamin is the NHS standard treatment and is usually lifelong. Notably, a Cochrane review of oral versus intramuscular B12 in B12 deficiency found low-quality evidence that the two routes had similar effects on normalising serum B12 levels, with oral treatment costing less — a reminder that 'injected' does not automatically mean 'superior'.
Other prescribed intravenous indications
Intravenous antibiotics, chemotherapy, immunoglobulin and other hospital treatments are given by that route because the drug requires it, or because the patient's condition demands rapid and reliable delivery. These are clinical decisions, not lifestyle ones.
The common thread is that each of these follows a diagnosis. Someone is found — usually on examination and blood testing — to have a specific deficit that the intravenous route is the right way to correct. The evidence supports the treatment of that deficit; it does not extend to giving the same infusion to a person who does not have it.
Sources: NICE CG174 — Intravenous fluid therapy in adults in hospital (guidance overview); Abridged Cochrane review — Intravenous iron therapy for adults with non-anaemic iron deficiency (PMC); Cochrane Review — Oral vitamin B12 compared with intramuscular vitamin B12 for vitamin B12 deficiency (Wang et al., 2018); NHS — Vitamin B12 or folate deficiency anaemia: treatment (hydroxocobalamin injections)
Which IV drip claims are marketed but not well supported in healthy people?
Claims that vitamin drips raise energy, improve immune function, relieve hangover symptoms or enhance athletic performance in otherwise healthy adults are not supported by good-quality published trials. A 2025 review of intravenous vitamin therapy concluded the reported benefits rest largely on anecdote and self-reported outcomes rather than well-designed randomised trials.
The point below is not that these infusions have been proven useless. In several cases they have simply not been tested properly, which is a different — and, for a patient deciding how to spend money, equally important — statement.
| Marketed claim | What the published evidence shows |
|---|---|
| General 'wellness' or energy infusions in healthy adults | A 2025 narrative review in Cureus found the purported benefits are primarily anecdotal or based on self-reported outcomes rather than well-designed randomised clinical trials, and identified a substantial evidence gap in otherwise healthy populations. |
| Infusions that strengthen the immune system | There is no good-quality randomised evidence that vitamin infusions improve immune function or reduce infections in healthy, non-deficient adults. Claims of this kind are also restricted under Dubai's health advertising rules. |
| Hangover drips | Systematic reviews of hangover interventions have consistently failed to find compelling evidence. A 2005 BMJ systematic review of randomised trials concluded no compelling evidence supported any conventional or complementary intervention; a 2022 review in Addiction of 21 placebo-controlled trials found the evidence very low quality throughout, with no remedy independently replicated. |
| Athletic performance and faster recovery | Evidence here is sparse and mostly small, short-term and unblinded. Rehydration matters to performance, but there is no good trial evidence that intravenous rehydration outperforms drinking fluids in an athlete who is able to drink. |
| Correcting a deficiency the person has not been shown to have | Treating an unmeasured deficiency is not evidence-based practice in either direction. If a deficiency is suspected, the established pathway is assessment and testing first, then targeted replacement. |
A frequently repeated figure worth ignoring
Marketing for IV drips often quotes a fixed comparison between intravenous and oral absorption — commonly framed as near-total absorption by drip versus a small fraction by mouth. Absorption varies widely by nutrient, dose and individual, and no single pair of numbers describes it. This site does not repeat that claim.
Sources: Alangari A. To IV or Not to IV: The Science Behind Intravenous Vitamin Therapy. Cureus, 2025 (PMC); Pittler MH et al. Interventions for preventing or treating alcohol hangover: systematic review of randomised controlled trials. BMJ, 2005 (PMC); Roberts E et al. Efficacy and tolerability of pharmacologically active interventions for alcohol-induced hangover symptomatology: a systematic review. Addiction, 2022 (PubMed); King's College London (IoPPN) — news summary of the Addiction 2022 systematic review of hangover remedies
Does bypassing digestion make an IV drip better than oral vitamins?
Only when digestion or absorption is actually the problem. In a person with a normal gut, the bloodstream is not the bottleneck: plasma concentrations of water-soluble vitamins are tightly regulated, and what the body does not need is largely excreted in the urine rather than stored for later use.
The 'bypasses the gut' argument is valid in a narrow set of circumstances — pernicious anaemia, coeliac disease, Crohn's disease, bariatric surgery, short bowel syndrome, and other states where oral intake genuinely does not reach the bloodstream. In those cases the intravenous or intramuscular route solves a real mechanical problem, which is precisely why it is the standard of care there.
In someone absorbing normally, the reasoning does not carry across. The NIH Office of Dietary Supplements notes that the body tightly controls tissue and plasma concentrations of vitamin C: roughly 70–90% is absorbed at moderate oral intakes, absorption falls below 50% at doses above 1 g per day, and absorbed, unmetabolised ascorbic acid is excreted in the urine. Delivering a larger dose intravenously raises the blood level briefly, but the surplus is still cleared by the kidneys.
Higher blood levels are not the same as better health
A temporary rise in a blood measurement is a surrogate marker, not an outcome. The clinically meaningful question is whether a person feels better, functions better or avoids illness — and for wellness infusions in healthy adults, that question has largely not been answered by good trials.
Fat-soluble vitamins behave differently and are the more serious concern, because they are stored rather than excreted, so repeated high doses can accumulate. That is a safety issue rather than an efficacy one, and it is covered in the risk section below.
Sources: NIH Office of Dietary Supplements — Vitamin C: Fact Sheet for Health Professionals; NIH Office of Dietary Supplements — Vitamin A and Carotenoids: Fact Sheet for Health Professionals
What are the risks and side effects of an IV drip?
Any infusion involves placing a cannula into a vein and delivering fluid and substances directly into the circulation. Documented risks include local vein problems, infiltration and extravasation, bloodstream infection, allergic and anaphylactic reactions, fluid overload, electrolyte disturbance, vitamin toxicity, drug interactions, and the possibility of masking an undiagnosed illness.
| Risk | What it involves |
|---|---|
| Cannulation problems | Pain, bruising, haematoma, repeated attempts to find a vein, and occasionally nerve irritation at the insertion site. |
| Infiltration and extravasation | Fluid leaking out of the vein into surrounding tissue, causing swelling and pain. With irritant solutions this can cause tissue damage and needs to be recognised and managed promptly. |
| Phlebitis and vein damage | Inflammation of the vein wall, which can present as a tender, reddened, hardened cord along the vein. Repeated cannulation over time can damage or collapse veins. |
| Bloodstream infection and sepsis | The cannula creates a direct route past the skin's barrier. The US FDA has documented sterile-compounding failures at clinics preparing IV vitamin infusions, including a case of suspected septic shock with multi-organ failure following a contaminated infusion. |
| Allergic and anaphylactic reactions | Reactions to an infused substance can develop rapidly and range from rash and itching to anaphylaxis. Infusion reactions are specifically documented with intravenous iron preparations. |
| Fluid overload | Delivering volume faster than the circulation can accommodate. This is a particular danger in heart failure and in kidney impairment, and can result in breathlessness and pulmonary oedema. |
| Electrolyte disturbance | Hyponatraemia and other electrolyte abnormalities are recognised complications of inappropriate IV fluid, which is why hospital guidance requires the composition and rate to be prescribed and monitored. |
| Vitamin toxicity | Fat-soluble vitamins accumulate rather than being excreted, so repeated high doses risk toxicity. High-dose vitamin C has been reported in case reports to cause oxalate nephropathy and acute kidney injury, and a review of 14 published cases of vitamin C-induced haemolysis found G6PD deficiency in 10 of them — a condition that is not rare in parts of the Middle East and South Asia. These reports involve doses far above those in a typical vitamin infusion, and at least one critical-care author argues vitamin C should not be treated as contraindicated in G6PD deficiency at lower doses; the dose and the individual both matter, which is why this is a question for a doctor rather than a menu. |
| Drug and condition interactions | Infused substances can interact with prescribed medicines and with existing conditions. High-dose vitamin C is also known to interfere with some point-of-care glucose meter readings, which matters for people with diabetes. |
| Masking an undiagnosed condition | Persistent fatigue, breathlessness, headaches or brain fog can be symptoms of thyroid disease, anaemia, sleep apnoea, diabetes, depression, cardiac or kidney disease. Treating the symptom with an infusion, without an assessment, can delay a diagnosis that matters. |
Seek urgent medical help
During or after an infusion, chest pain, breathlessness, facial or throat swelling, widespread rash, dizziness or fainting, or a spreading redness, heat and pain at the cannula site all need urgent medical assessment rather than reassurance.
Sources: FDA — Concerns with compounding of drug products by medical offices and clinics under insanitary conditions; NABP, FSMB and NCSBN — joint education with federal agencies on the risks of IV hydration clinics; Vitamin C-induced haemolysis: meta-summary and review of the literature. Indian J Crit Care Med, 2022 (PMC); Marik PE. Is intravenous vitamin C contraindicated in patients with G6PD deficiency? Critical Care, 2019 — argues it is not, at the doses used in sepsis trials (PMC); Vitamin C-induced oxalate nephropathy: a case report (PMC); NIH Office of Dietary Supplements — Vitamin C: Fact Sheet for Health Professionals (interactions, including glucose-meter interference); NICE CG174 — Intravenous fluid therapy in adults in hospital (guidance overview)
Who should avoid elective IV drips?
Elective, non-medically-indicated infusions are inappropriate for anyone whose circulation, kidneys or metabolism cannot safely handle an extra fluid and solute load, anyone with a relevant allergy, and anyone whose symptoms have not been investigated. In these situations the correct step is a medical assessment, not an infusion.
- People with heart failure or significant cardiac impairment, in whom added intravenous volume can precipitate fluid overload.
- People with kidney impairment or on dialysis, who cannot clear a fluid, electrolyte or vitamin load normally.
- People with liver disease, in whom fluid balance and drug handling are already altered.
- People with G6PD deficiency, particularly where high-dose vitamin C is involved.
- People with a history of allergic or anaphylactic reaction to any infused component, including iron preparations.
- People with uncontrolled hypertension or a condition requiring strict fluid or sodium restriction.
- People who are pregnant or breastfeeding, unless a doctor has judged an infusion clinically necessary.
- Children and adolescents, outside a clinical indication assessed by a paediatric clinician.
- Anyone with new, persistent or worsening symptoms that have not yet been investigated — fatigue, breathlessness, weight loss, palpitations or recurrent infections all warrant diagnosis first.
- Anyone who is acutely unwell, feverish, or suspected of having an infection, who needs urgent clinical assessment rather than an elective drip.
This list is illustrative rather than exhaustive. Existing prescriptions, supplements and past reactions all change the calculation, which is one reason a proper history is not a formality.
Sources: NICE CG174 — Intravenous fluid therapy in adults in hospital (assessment, fluid overload and electrolyte monitoring); Vitamin C-induced haemolysis: meta-summary and review of the literature. Indian J Crit Care Med, 2022 (PMC); Systematic review and meta-analysis of intravenous iron therapy for adults with non-anaemic iron deficiency: an abridged Cochrane review (PMC); NABP, FSMB and NCSBN — joint education with federal agencies on the risks of IV hydration clinics
How should a provider of IV therapy be evaluated?
The relevant checks are regulatory and clinical: the facility should be licensed by the health authority, a licensed clinician should assess the person before any infusion, prescription components require a prescriber, consent should be genuinely informed, and the site should be equipped and trained to manage a reaction.
- 1
Confirm the facility and clinician are licensed
In Dubai, healthcare facilities and professionals are licensed and inspected by the Dubai Health Authority, and licence status can be checked through the DHA's Sheryan licensing system. Facilities in Dubai Healthcare City are regulated separately by DHCC. A verifiable licence is a minimum, not a distinguishing feature.
- 2
Expect a clinical assessment before anything is infused
A history, medication review, allergy check and relevant examination should come first, with blood tests where a deficiency is being claimed or suspected. An infusion offered from a menu without an assessment inverts the correct order.
- 3
Check that prescription components have a prescriber
Many infusion ingredients are prescription-only medicines. A licensed doctor must decide they are appropriate for that individual and prescribe them; a non-prescribing staff member cannot make that decision.
- 4
Ask how the product is prepared
Regulators have repeatedly flagged unsafe sterile compounding as the source of serious infections at infusion clinics. It is reasonable to ask where the preparation is compounded, under what conditions, and by whom.
- 5
Insist on genuinely informed consent
Consent should cover the specific contents and doses, the intended purpose, the strength of evidence behind it, the risks, the alternatives — including doing nothing or addressing the issue orally — and the cost, in writing and before treatment.
- 6
Confirm emergency preparedness
The site should have resuscitation equipment, adrenaline for anaphylaxis, trained staff, an observation period after the infusion, and a defined escalation route to emergency care.
- 7
Treat marketing language as a warning sign
Promises of a certain outcome, claims that a drip carries no risk at all, pressure to buy packages, or offers made without any assessment are inconsistent with how a regulated medical service should present itself. Dubai's health advertising rules restrict absolute and superlative claims for exactly this reason.
Sources: Dubai Health Authority — Sheryan licensing system; Dubai Health Authority — Dubai health licensing system (Sheryan) overview; FDA — Concerns with compounding of drug products by medical offices and clinics under insanitary conditions
What questions are worth asking before booking an IV drip?
A short list of direct questions separates a clinical service from a retail one. A provider that answers all of them clearly, in writing, and is willing to say when the evidence is weak, is behaving the way a regulated medical service should.
- 01Is this facility licensed by the DHA (or DHCC), and can the licence be verified?
- 02Which licensed doctor will assess me, and will that happen before anything is infused?
- 03Exactly which substances and doses will be in the infusion, and can I have that in writing?
- 04Which of those are prescription-only medicines, and who is prescribing them?
- 05What specific evidence supports this infusion for someone in my situation — and where is the evidence weak or absent?
- 06Do I actually have a measured deficiency, or is this being given without testing?
- 07What are the risks and side effects, and what would you do if I had a reaction?
- 08How and where is the infusion prepared, and under what sterility conditions?
- 09Is there a cheaper, lower-risk option — such as oral treatment or simply drinking fluids — that would work as well for me?
- 10What is the total cost, and what happens if the infusion has to be stopped partway?
Where to start
Anyone considering intravenous treatment in Dubai should begin with a consultation at a DHA-licensed facility where a doctor assesses whether an infusion is clinically appropriate at all. Verify the facility and clinician licences, ask for the evidence behind each ingredient, and choose a provider willing to recommend testing, oral treatment or no treatment instead.
Frequently asked questions
Are IV drips safe?
Intravenous infusions given for a clinical indication, in a licensed facility, after a proper assessment, are a routine part of medical care. They are not risk-free in any setting: documented risks include vein inflammation, infiltration, bloodstream infection, allergic and anaphylactic reactions, fluid overload, electrolyte disturbance and, with repeated high doses, vitamin toxicity. The risk-benefit balance is very different when there is no clinical indication in the first place.
Do vitamin drips give you more energy?
There is no good-quality randomised trial evidence that vitamin infusions increase energy in healthy adults who are not deficient. A 2025 review of intravenous vitamin therapy concluded that reported benefits rest largely on anecdote and self-reported outcomes. Where fatigue is persistent, it is worth investigating properly — iron deficiency, thyroid disease, sleep apnoea, diabetes and depression are all common and treatable causes that an infusion would not address.
Is an IV drip better than taking oral vitamins?
It depends entirely on whether absorption is the problem. In pernicious anaemia, coeliac disease, Crohn's disease or after bariatric surgery, the parenteral route solves a genuine absorption barrier and is standard care. In a person absorbing normally, plasma levels of water-soluble vitamins are tightly regulated and the excess is largely excreted in urine. Notably, a Cochrane review found low-quality evidence that oral and intramuscular vitamin B12 had similar effects on normalising serum B12 levels, with oral treatment costing less.
Do hangover drips work?
Systematic reviews of hangover treatments have not found compelling evidence for any intervention. A 2005 BMJ review of randomised controlled trials found no compelling evidence for any conventional or complementary treatment, and a 2022 review in Addiction assessing 21 placebo-controlled trials rated all the evidence very low quality with no remedy independently replicated.
Can an IV drip be done at home in Dubai?
Home healthcare in Dubai is a separately regulated activity with its own licensing requirements, and home-based clinical services are restricted to defined categories of patient rather than being available on request. Anyone offered a home infusion should verify what licence the provider holds for delivering care outside a facility, and should consider that a home setting is a harder environment in which to manage a severe reaction.
How much does IV drip therapy cost in Dubai?
Prices vary considerably between providers and depend on what is actually being given, so no single figure is meaningful. Ask for an itemised cost after a doctor has established whether an infusion is clinically appropriate. Advertised package pricing should be treated with caution when it is offered before any assessment has taken place.
What should someone do if they think they have a vitamin deficiency?
The established pathway is assessment and testing before treatment. A doctor can take a history, examine, and order the relevant blood tests, then treat what is actually found — which may be oral supplementation, a dietary change, investigation of an underlying cause, or in specific cases a parenteral treatment such as iron or vitamin B12. Treating a deficiency that has not been demonstrated is neither necessary nor evidence-based.